Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:48 AM
Ignite Modification Date:
2025-12-24 @ 11:48 AM
NCT ID:
NCT01285661
Eligibility Criteria:
Inclusion Criteria:
* Patients with proximal DVT that is idiopathic or secondary to minor factors for thrombosis, with or without contemporary manifestations of PE, who have completed an uneventful 3 to 24-month period of anticoagulation and are available for an overall 48-month follow-up at the study centre.
Exclusion Criteria:
* previous thromboembolism
* recent (less than 3 months) major trauma or surgery
* active cancer
* immobilization resulting from chronic irreversible medical diseases
* need for indefinite anticoagulation for medical reasons other than VTE
* impossibility to attend the follow-up visits or to have D-dimer determinations
* already known major thrombophilia: carriage of deficiencies of natural anticoagulants, lupus-like anticoagulants, homozygosis for factor V Leiden or prothrombin mutation, heterozygosis for both abnormalities
* short (less than 1 year) life expectancy
* pregnancy
* age younger than 18
* refusal of informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01285661
Study Brief:
Protocol Section:
NCT01285661